Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Malignant T-cell-amplified sequence 1 | ||
Ligand | BDBM403188 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | MTT assay | ||
EC50 | <20.0±n/a nM | ||
Citation | Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL Heterocyclic inhibitors of monocarboxylate transporter US Patent US10329303 Publication Date 6/25/2019 | ||
More Info.: | Get all data from this article, Assay Method | ||
Malignant T-cell-amplified sequence 1 | |||
Name: | Malignant T-cell-amplified sequence 1 | ||
Synonyms: | MCT-1 | MCT1 | MCTS1 | MCTS1_HUMAN | Multiple copies T-cell malignancies | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 20563.62 | ||
Organism: | Homo sapiens (human) | ||
Description: | n/a | ||
Residue: | 181 | ||
Sequence: |
| ||
BDBM403188 | |||
n/a | |||
Name | BDBM403188 | ||
Synonyms: | US10329303, Example 21 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H28F2N4O3S | ||
Mol. Mass. | 514.587 | ||
SMILES | CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3ccc(F)c(CO)c3F)c2c(=O)n(C2CC2)c1=O |(-3.39,-6.29,;-3.39,-4.75,;-4.73,-3.98,;-2.06,-3.98,;-2.06,-2.44,;-.72,-1.67,;.74,-2.15,;1.65,-.9,;3.19,-.9,;3.96,-2.24,;3.48,-3.7,;2.15,-4.47,;4.73,-4.61,;5.97,-3.7,;5.5,-2.24,;6.27,-.9,;.74,.34,;1.14,1.83,;.05,2.92,;.45,4.41,;1.94,4.81,;2.33,6.29,;3.02,3.72,;4.51,4.12,;5.6,3.03,;2.63,2.23,;3.72,1.14,;-.72,-.13,;-2.06,.64,;-2.06,2.18,;-3.39,-.13,;-4.73,.64,;-6.27,.64,;-5.5,1.97,;-3.39,-1.67,;-4.73,-2.44,)| | ||
Structure |